0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharma Grade NAC (Acetylcysteine) Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-32D15415
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharma Grade NAC Acetylcysteine Market Research Report 2023
BUY CHAPTERS

Global Pharma Grade NAC (Acetylcysteine) Market Research Report 2025

Code: QYRE-Auto-32D15415
Report
June 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pharma Grade NAC (Acetylcysteine) Market Size

The global market for Pharma Grade NAC (Acetylcysteine) was valued at US$ 101 million in the year 2024 and is projected to reach a revised size of US$ 181 million by 2031, growing at a CAGR of 8.2% during the forecast period.

Pharma Grade NAC (Acetylcysteine) Market

Pharma Grade NAC (Acetylcysteine) Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Pharma Grade NAC (Acetylcysteine) competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Pharma Grade NAC (Acetylcysteine) refers to a high-purity, pharmaceutical-quality form of acetylcysteine that meets stringent standards required for use in medical and clinical applications. Derived from the amino acid L-cysteine, NAC is chemically designated as C₅H₉NO₃S. It acts primarily as a mucolytic agent and as a precursor to glutathione, the body’s most vital antioxidant. Pharma grade NAC is manufactured under Good Manufacturing Practices (GMP), complying with pharmacopeial standards such as the United States Pharmacopeia (USP), European Pharmacopoeia (Ph. Eur.), or Japanese Pharmacopoeia (JP). These standards ensure the product is free from contaminants, has high bioavailability, and is suitable for medical administration, whether orally, intravenously, or via inhalation.
Pharmaceutical-grade NAC is used in several critical therapeutic areas. One of its most recognized uses is in the treatment of acetaminophen (paracetamol) overdose, a common cause of acute liver failure. In this role, NAC replenishes intracellular glutathione stores, allowing for detoxification of the toxic metabolite NAPQI, and is life-saving if administered in time. Another primary application of pharma grade NAC is in the management of chronic respiratory disorders such as chronic obstructive pulmonary disease (COPD), bronchitis, and cystic fibrosis. By disrupting disulfide bonds in mucus, NAC reduces viscosity, thereby facilitating expectoration and improving airflow.
Additionally, pharma grade NAC is being increasingly studied for its potential neuroprotective and psychiatric benefits, including its use as an adjunctive therapy in conditions such as bipolar disorder, obsessive-compulsive disorder, and schizophrenia. In these applications, NAC is believed to modulate glutamatergic pathways and oxidative stress, two mechanisms implicated in the pathophysiology of various mental health disorders. These evolving indications are expanding the boundaries of pharmaceutical NAC usage, supported by growing clinical evidence and ongoing trials.
The World Health Organization (WHO) estimates that over 300 million people worldwide suffer from COPD, with millions more affected by asthma, bronchiectasis, and cystic fibrosis. Pharma grade NAC’s mucolytic action has made it a mainstay in the management of these conditions. In Europe and parts of Asia, especially China and Japan, NAC is regularly prescribed as a standard part of treatment regimens for chronic bronchitis and pulmonary rehabilitation. The increasing availability of hospital-grade nebulizers and inhalation therapies is pushing adoption of high-purity, pharma grade NAC in clinical respiratory care.
From a geographic standpoint, Europe and Asia-Pacific lead the market in terms of volume and revenue, driven by government healthcare programs, favorable reimbursement policies, and a higher number of patients with respiratory disorders. In Europe, countries such as Germany, Italy, France, and Spain have well-established NAC treatment protocols, and several local manufacturers specialize in pharma grade formulations. China, a major global manufacturer of pharmaceutical intermediates, has become a central hub for NAC production, supplying both domestic and international pharmaceutical companies. India, too, is emerging as a significant producer and consumer, due to lower manufacturing costs and a growing pharmaceutical export base.
A growing area of interest—and a key future market driver—is the expanding clinical research into NAC’s neuropsychiatric applications. Studies have indicated that NAC may support treatment for disorders such as autism spectrum disorder (ASD), depression, addiction, and obsessive-compulsive disorder (OCD). Although off-label use currently dominates this segment, ongoing clinical trials and potential future approvals may lead to a significant expansion in pharma grade NAC's indications. Pharmaceutical companies involved in psychiatric and neurological drug development are increasingly exploring NAC's role in combination therapies, which could reshape the therapeutic landscape.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pharma Grade NAC (Acetylcysteine), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharma Grade NAC (Acetylcysteine).
The Pharma Grade NAC (Acetylcysteine) market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharma Grade NAC (Acetylcysteine) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharma Grade NAC (Acetylcysteine) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pharma Grade NAC (Acetylcysteine) Market Report

Report Metric Details
Report Name Pharma Grade NAC (Acetylcysteine) Market
Accounted market size in year US$ 101 million
Forecasted market size in 2031 US$ 181 million
CAGR 8.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Pharmacy
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Zambon, Moehs, Axplora, Nippon Rika, Chengyi Pharma, Wuhan Grand Hoyo, Manus Aktteva Biopharma, Shine Star Biological, Huachang Pharmaceutical, Xinhanling Biological, Shuguang Biological
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pharma Grade NAC (Acetylcysteine) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Pharma Grade NAC (Acetylcysteine) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Pharma Grade NAC (Acetylcysteine) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

How fast is Pharma Grade NAC (Acetylcysteine) Market growing?

Ans: The Pharma Grade NAC (Acetylcysteine) Market witnessing a CAGR of 8.2% during the forecast period 2025-2031.

What is the Pharma Grade NAC (Acetylcysteine) Market size in 2031?

Ans: The Pharma Grade NAC (Acetylcysteine) Market size in 2031 will be US$ 181 million.

Who are the main players in the Pharma Grade NAC (Acetylcysteine) Market report?

Ans: The main players in the Pharma Grade NAC (Acetylcysteine) Market are Zambon, Moehs, Axplora, Nippon Rika, Chengyi Pharma, Wuhan Grand Hoyo, Manus Aktteva Biopharma, Shine Star Biological, Huachang Pharmaceutical, Xinhanling Biological, Shuguang Biological

What are the Application segmentation covered in the Pharma Grade NAC (Acetylcysteine) Market report?

Ans: The Applications covered in the Pharma Grade NAC (Acetylcysteine) Market report are Hospital, Clinic, Pharmacy, Others

What are the Type segmentation covered in the Pharma Grade NAC (Acetylcysteine) Market report?

Ans: The Types covered in the Pharma Grade NAC (Acetylcysteine) Market report are Injection, Granule for Oral Solution, Oral Inhalation, Effervescent Tablets, Others

Recommended Reports

Pharma Grade Ingredients

Pharmaceutical Acetyl Compounds

Pharma Grade Sodium Compounds

1 Pharma Grade NAC (Acetylcysteine) Market Overview
1.1 Product Definition
1.2 Pharma Grade NAC (Acetylcysteine) by Type
1.2.1 Global Pharma Grade NAC (Acetylcysteine) Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Injection
1.2.3 Granule for Oral Solution
1.2.4 Oral Inhalation
1.2.5 Effervescent Tablets
1.2.6 Others
1.3 Pharma Grade NAC (Acetylcysteine) by Application
1.3.1 Global Pharma Grade NAC (Acetylcysteine) Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Pharma Grade NAC (Acetylcysteine) Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Pharma Grade NAC (Acetylcysteine) Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Pharma Grade NAC (Acetylcysteine) Production Estimates and Forecasts (2020-2031)
1.4.4 Global Pharma Grade NAC (Acetylcysteine) Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Pharma Grade NAC (Acetylcysteine) Production Market Share by Manufacturers (2020-2025)
2.2 Global Pharma Grade NAC (Acetylcysteine) Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Pharma Grade NAC (Acetylcysteine), Industry Ranking, 2023 VS 2024
2.4 Global Pharma Grade NAC (Acetylcysteine) Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Pharma Grade NAC (Acetylcysteine) Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Pharma Grade NAC (Acetylcysteine), Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Pharma Grade NAC (Acetylcysteine), Product Offered and Application
2.8 Global Key Manufacturers of Pharma Grade NAC (Acetylcysteine), Date of Enter into This Industry
2.9 Pharma Grade NAC (Acetylcysteine) Market Competitive Situation and Trends
2.9.1 Pharma Grade NAC (Acetylcysteine) Market Concentration Rate
2.9.2 Global 5 and 10 Largest Pharma Grade NAC (Acetylcysteine) Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Pharma Grade NAC (Acetylcysteine) Production by Region
3.1 Global Pharma Grade NAC (Acetylcysteine) Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Pharma Grade NAC (Acetylcysteine) Production Value by Region (2020-2031)
3.2.1 Global Pharma Grade NAC (Acetylcysteine) Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Pharma Grade NAC (Acetylcysteine) by Region (2026-2031)
3.3 Global Pharma Grade NAC (Acetylcysteine) Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Pharma Grade NAC (Acetylcysteine) Production Volume by Region (2020-2031)
3.4.1 Global Pharma Grade NAC (Acetylcysteine) Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Pharma Grade NAC (Acetylcysteine) by Region (2026-2031)
3.5 Global Pharma Grade NAC (Acetylcysteine) Market Price Analysis by Region (2020-2025)
3.6 Global Pharma Grade NAC (Acetylcysteine) Production and Value, Year-over-Year Growth
3.6.1 North America Pharma Grade NAC (Acetylcysteine) Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Pharma Grade NAC (Acetylcysteine) Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Pharma Grade NAC (Acetylcysteine) Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Pharma Grade NAC (Acetylcysteine) Production Value Estimates and Forecasts (2020-2031)
4 Pharma Grade NAC (Acetylcysteine) Consumption by Region
4.1 Global Pharma Grade NAC (Acetylcysteine) Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Pharma Grade NAC (Acetylcysteine) Consumption by Region (2020-2031)
4.2.1 Global Pharma Grade NAC (Acetylcysteine) Consumption by Region (2020-2025)
4.2.2 Global Pharma Grade NAC (Acetylcysteine) Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Pharma Grade NAC (Acetylcysteine) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Pharma Grade NAC (Acetylcysteine) Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Pharma Grade NAC (Acetylcysteine) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Pharma Grade NAC (Acetylcysteine) Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Pharma Grade NAC (Acetylcysteine) Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Pharma Grade NAC (Acetylcysteine) Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Pharma Grade NAC (Acetylcysteine) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Pharma Grade NAC (Acetylcysteine) Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Pharma Grade NAC (Acetylcysteine) Production by Type (2020-2031)
5.1.1 Global Pharma Grade NAC (Acetylcysteine) Production by Type (2020-2025)
5.1.2 Global Pharma Grade NAC (Acetylcysteine) Production by Type (2026-2031)
5.1.3 Global Pharma Grade NAC (Acetylcysteine) Production Market Share by Type (2020-2031)
5.2 Global Pharma Grade NAC (Acetylcysteine) Production Value by Type (2020-2031)
5.2.1 Global Pharma Grade NAC (Acetylcysteine) Production Value by Type (2020-2025)
5.2.2 Global Pharma Grade NAC (Acetylcysteine) Production Value by Type (2026-2031)
5.2.3 Global Pharma Grade NAC (Acetylcysteine) Production Value Market Share by Type (2020-2031)
5.3 Global Pharma Grade NAC (Acetylcysteine) Price by Type (2020-2031)
6 Segment by Application
6.1 Global Pharma Grade NAC (Acetylcysteine) Production by Application (2020-2031)
6.1.1 Global Pharma Grade NAC (Acetylcysteine) Production by Application (2020-2025)
6.1.2 Global Pharma Grade NAC (Acetylcysteine) Production by Application (2026-2031)
6.1.3 Global Pharma Grade NAC (Acetylcysteine) Production Market Share by Application (2020-2031)
6.2 Global Pharma Grade NAC (Acetylcysteine) Production Value by Application (2020-2031)
6.2.1 Global Pharma Grade NAC (Acetylcysteine) Production Value by Application (2020-2025)
6.2.2 Global Pharma Grade NAC (Acetylcysteine) Production Value by Application (2026-2031)
6.2.3 Global Pharma Grade NAC (Acetylcysteine) Production Value Market Share by Application (2020-2031)
6.3 Global Pharma Grade NAC (Acetylcysteine) Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Zambon
7.1.1 Zambon Pharma Grade NAC (Acetylcysteine) Company Information
7.1.2 Zambon Pharma Grade NAC (Acetylcysteine) Product Portfolio
7.1.3 Zambon Pharma Grade NAC (Acetylcysteine) Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Zambon Main Business and Markets Served
7.1.5 Zambon Recent Developments/Updates
7.2 Moehs
7.2.1 Moehs Pharma Grade NAC (Acetylcysteine) Company Information
7.2.2 Moehs Pharma Grade NAC (Acetylcysteine) Product Portfolio
7.2.3 Moehs Pharma Grade NAC (Acetylcysteine) Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Moehs Main Business and Markets Served
7.2.5 Moehs Recent Developments/Updates
7.3 Axplora
7.3.1 Axplora Pharma Grade NAC (Acetylcysteine) Company Information
7.3.2 Axplora Pharma Grade NAC (Acetylcysteine) Product Portfolio
7.3.3 Axplora Pharma Grade NAC (Acetylcysteine) Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Axplora Main Business and Markets Served
7.3.5 Axplora Recent Developments/Updates
7.4 Nippon Rika
7.4.1 Nippon Rika Pharma Grade NAC (Acetylcysteine) Company Information
7.4.2 Nippon Rika Pharma Grade NAC (Acetylcysteine) Product Portfolio
7.4.3 Nippon Rika Pharma Grade NAC (Acetylcysteine) Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Nippon Rika Main Business and Markets Served
7.4.5 Nippon Rika Recent Developments/Updates
7.5 Chengyi Pharma
7.5.1 Chengyi Pharma Pharma Grade NAC (Acetylcysteine) Company Information
7.5.2 Chengyi Pharma Pharma Grade NAC (Acetylcysteine) Product Portfolio
7.5.3 Chengyi Pharma Pharma Grade NAC (Acetylcysteine) Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Chengyi Pharma Main Business and Markets Served
7.5.5 Chengyi Pharma Recent Developments/Updates
7.6 Wuhan Grand Hoyo
7.6.1 Wuhan Grand Hoyo Pharma Grade NAC (Acetylcysteine) Company Information
7.6.2 Wuhan Grand Hoyo Pharma Grade NAC (Acetylcysteine) Product Portfolio
7.6.3 Wuhan Grand Hoyo Pharma Grade NAC (Acetylcysteine) Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Wuhan Grand Hoyo Main Business and Markets Served
7.6.5 Wuhan Grand Hoyo Recent Developments/Updates
7.7 Manus Aktteva Biopharma
7.7.1 Manus Aktteva Biopharma Pharma Grade NAC (Acetylcysteine) Company Information
7.7.2 Manus Aktteva Biopharma Pharma Grade NAC (Acetylcysteine) Product Portfolio
7.7.3 Manus Aktteva Biopharma Pharma Grade NAC (Acetylcysteine) Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Manus Aktteva Biopharma Main Business and Markets Served
7.7.5 Manus Aktteva Biopharma Recent Developments/Updates
7.8 Shine Star Biological
7.8.1 Shine Star Biological Pharma Grade NAC (Acetylcysteine) Company Information
7.8.2 Shine Star Biological Pharma Grade NAC (Acetylcysteine) Product Portfolio
7.8.3 Shine Star Biological Pharma Grade NAC (Acetylcysteine) Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Shine Star Biological Main Business and Markets Served
7.8.5 Shine Star Biological Recent Developments/Updates
7.9 Huachang Pharmaceutical
7.9.1 Huachang Pharmaceutical Pharma Grade NAC (Acetylcysteine) Company Information
7.9.2 Huachang Pharmaceutical Pharma Grade NAC (Acetylcysteine) Product Portfolio
7.9.3 Huachang Pharmaceutical Pharma Grade NAC (Acetylcysteine) Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Huachang Pharmaceutical Main Business and Markets Served
7.9.5 Huachang Pharmaceutical Recent Developments/Updates
7.10 Xinhanling Biological
7.10.1 Xinhanling Biological Pharma Grade NAC (Acetylcysteine) Company Information
7.10.2 Xinhanling Biological Pharma Grade NAC (Acetylcysteine) Product Portfolio
7.10.3 Xinhanling Biological Pharma Grade NAC (Acetylcysteine) Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Xinhanling Biological Main Business and Markets Served
7.10.5 Xinhanling Biological Recent Developments/Updates
7.11 Shuguang Biological
7.11.1 Shuguang Biological Pharma Grade NAC (Acetylcysteine) Company Information
7.11.2 Shuguang Biological Pharma Grade NAC (Acetylcysteine) Product Portfolio
7.11.3 Shuguang Biological Pharma Grade NAC (Acetylcysteine) Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Shuguang Biological Main Business and Markets Served
7.11.5 Shuguang Biological Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Pharma Grade NAC (Acetylcysteine) Industry Chain Analysis
8.2 Pharma Grade NAC (Acetylcysteine) Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Pharma Grade NAC (Acetylcysteine) Production Mode & Process Analysis
8.4 Pharma Grade NAC (Acetylcysteine) Sales and Marketing
8.4.1 Pharma Grade NAC (Acetylcysteine) Sales Channels
8.4.2 Pharma Grade NAC (Acetylcysteine) Distributors
8.5 Pharma Grade NAC (Acetylcysteine) Customer Analysis
9 Pharma Grade NAC (Acetylcysteine) Market Dynamics
9.1 Pharma Grade NAC (Acetylcysteine) Industry Trends
9.2 Pharma Grade NAC (Acetylcysteine) Market Drivers
9.3 Pharma Grade NAC (Acetylcysteine) Market Challenges
9.4 Pharma Grade NAC (Acetylcysteine) Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
 Table 1. Global Pharma Grade NAC (Acetylcysteine) Market Value by Type, (US$ Million) & (2024 VS 2031)
 Table 2. Global Pharma Grade NAC (Acetylcysteine) Market Value by Application, (US$ Million) & (2024 VS 2031)
 Table 3. Global Pharma Grade NAC (Acetylcysteine) Production Capacity (Tons) by Manufacturers in 2024
 Table 4. Global Pharma Grade NAC (Acetylcysteine) Production by Manufacturers (2020-2025) & (Tons)
 Table 5. Global Pharma Grade NAC (Acetylcysteine) Production Market Share by Manufacturers (2020-2025)
 Table 6. Global Pharma Grade NAC (Acetylcysteine) Production Value by Manufacturers (2020-2025) & (US$ Million)
 Table 7. Global Pharma Grade NAC (Acetylcysteine) Production Value Share by Manufacturers (2020-2025)
 Table 8. Global Key Players of Pharma Grade NAC (Acetylcysteine), Industry Ranking, 2023 VS 2024
 Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Pharma Grade NAC (Acetylcysteine) as of 2024)
 Table 10. Global Market Pharma Grade NAC (Acetylcysteine) Average Price by Manufacturers (US$/kg) & (2020-2025)
 Table 11. Global Key Manufacturers of Pharma Grade NAC (Acetylcysteine), Manufacturing Base Distribution and Headquarters
 Table 12. Global Key Manufacturers of Pharma Grade NAC (Acetylcysteine), Product Offered and Application
 Table 13. Global Key Manufacturers of Pharma Grade NAC (Acetylcysteine), Date of Enter into This Industry
 Table 14. Global Pharma Grade NAC (Acetylcysteine) Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pharma Grade NAC (Acetylcysteine) Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Pharma Grade NAC (Acetylcysteine) Production Value (US$ Million) by Region (2020-2025)
 Table 18. Global Pharma Grade NAC (Acetylcysteine) Production Value Market Share by Region (2020-2025)
 Table 19. Global Pharma Grade NAC (Acetylcysteine) Production Value (US$ Million) Forecast by Region (2026-2031)
 Table 20. Global Pharma Grade NAC (Acetylcysteine) Production Value Market Share Forecast by Region (2026-2031)
 Table 21. Global Pharma Grade NAC (Acetylcysteine) Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 22. Global Pharma Grade NAC (Acetylcysteine) Production (Tons) by Region (2020-2025)
 Table 23. Global Pharma Grade NAC (Acetylcysteine) Production Market Share by Region (2020-2025)
 Table 24. Global Pharma Grade NAC (Acetylcysteine) Production (Tons) Forecast by Region (2026-2031)
 Table 25. Global Pharma Grade NAC (Acetylcysteine) Production Market Share Forecast by Region (2026-2031)
 Table 26. Global Pharma Grade NAC (Acetylcysteine) Market Average Price (US$/kg) by Region (2020-2025)
 Table 27. Global Pharma Grade NAC (Acetylcysteine) Market Average Price (US$/kg) by Region (2026-2031)
 Table 28. Global Pharma Grade NAC (Acetylcysteine) Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 29. Global Pharma Grade NAC (Acetylcysteine) Consumption by Region (2020-2025) & (Tons)
 Table 30. Global Pharma Grade NAC (Acetylcysteine) Consumption Market Share by Region (2020-2025)
 Table 31. Global Pharma Grade NAC (Acetylcysteine) Forecasted Consumption by Region (2026-2031) & (Tons)
 Table 32. Global Pharma Grade NAC (Acetylcysteine) Forecasted Consumption Market Share by Region (2026-2031)
 Table 33. North America Pharma Grade NAC (Acetylcysteine) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 34. North America Pharma Grade NAC (Acetylcysteine) Consumption by Country (2020-2025) & (Tons)
 Table 35. North America Pharma Grade NAC (Acetylcysteine) Consumption by Country (2026-2031) & (Tons)
 Table 36. Europe Pharma Grade NAC (Acetylcysteine) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 37. Europe Pharma Grade NAC (Acetylcysteine) Consumption by Country (2020-2025) & (Tons)
 Table 38. Europe Pharma Grade NAC (Acetylcysteine) Consumption by Country (2026-2031) & (Tons)
 Table 39. Asia Pacific Pharma Grade NAC (Acetylcysteine) Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 40. Asia Pacific Pharma Grade NAC (Acetylcysteine) Consumption by Region (2020-2025) & (Tons)
 Table 41. Asia Pacific Pharma Grade NAC (Acetylcysteine) Consumption by Region (2026-2031) & (Tons)
 Table 42. Latin America, Middle East & Africa Pharma Grade NAC (Acetylcysteine) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 43. Latin America, Middle East & Africa Pharma Grade NAC (Acetylcysteine) Consumption by Country (2020-2025) & (Tons)
 Table 44. Latin America, Middle East & Africa Pharma Grade NAC (Acetylcysteine) Consumption by Country (2026-2031) & (Tons)
 Table 45. Global Pharma Grade NAC (Acetylcysteine) Production (Tons) by Type (2020-2025)
 Table 46. Global Pharma Grade NAC (Acetylcysteine) Production (Tons) by Type (2026-2031)
 Table 47. Global Pharma Grade NAC (Acetylcysteine) Production Market Share by Type (2020-2025)
 Table 48. Global Pharma Grade NAC (Acetylcysteine) Production Market Share by Type (2026-2031)
 Table 49. Global Pharma Grade NAC (Acetylcysteine) Production Value (US$ Million) by Type (2020-2025)
 Table 50. Global Pharma Grade NAC (Acetylcysteine) Production Value (US$ Million) by Type (2026-2031)
 Table 51. Global Pharma Grade NAC (Acetylcysteine) Production Value Market Share by Type (2020-2025)
 Table 52. Global Pharma Grade NAC (Acetylcysteine) Production Value Market Share by Type (2026-2031)
 Table 53. Global Pharma Grade NAC (Acetylcysteine) Price (US$/kg) by Type (2020-2025)
 Table 54. Global Pharma Grade NAC (Acetylcysteine) Price (US$/kg) by Type (2026-2031)
 Table 55. Global Pharma Grade NAC (Acetylcysteine) Production (Tons) by Application (2020-2025)
 Table 56. Global Pharma Grade NAC (Acetylcysteine) Production (Tons) by Application (2026-2031)
 Table 57. Global Pharma Grade NAC (Acetylcysteine) Production Market Share by Application (2020-2025)
 Table 58. Global Pharma Grade NAC (Acetylcysteine) Production Market Share by Application (2026-2031)
 Table 59. Global Pharma Grade NAC (Acetylcysteine) Production Value (US$ Million) by Application (2020-2025)
 Table 60. Global Pharma Grade NAC (Acetylcysteine) Production Value (US$ Million) by Application (2026-2031)
 Table 61. Global Pharma Grade NAC (Acetylcysteine) Production Value Market Share by Application (2020-2025)
 Table 62. Global Pharma Grade NAC (Acetylcysteine) Production Value Market Share by Application (2026-2031)
 Table 63. Global Pharma Grade NAC (Acetylcysteine) Price (US$/kg) by Application (2020-2025)
 Table 64. Global Pharma Grade NAC (Acetylcysteine) Price (US$/kg) by Application (2026-2031)
 Table 65. Zambon Pharma Grade NAC (Acetylcysteine) Company Information
 Table 66. Zambon Pharma Grade NAC (Acetylcysteine) Specification and Application
 Table 67. Zambon Pharma Grade NAC (Acetylcysteine) Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 68. Zambon Main Business and Markets Served
 Table 69. Zambon Recent Developments/Updates
 Table 70. Moehs Pharma Grade NAC (Acetylcysteine) Company Information
 Table 71. Moehs Pharma Grade NAC (Acetylcysteine) Specification and Application
 Table 72. Moehs Pharma Grade NAC (Acetylcysteine) Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 73. Moehs Main Business and Markets Served
 Table 74. Moehs Recent Developments/Updates
 Table 75. Axplora Pharma Grade NAC (Acetylcysteine) Company Information
 Table 76. Axplora Pharma Grade NAC (Acetylcysteine) Specification and Application
 Table 77. Axplora Pharma Grade NAC (Acetylcysteine) Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 78. Axplora Main Business and Markets Served
 Table 79. Axplora Recent Developments/Updates
 Table 80. Nippon Rika Pharma Grade NAC (Acetylcysteine) Company Information
 Table 81. Nippon Rika Pharma Grade NAC (Acetylcysteine) Specification and Application
 Table 82. Nippon Rika Pharma Grade NAC (Acetylcysteine) Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 83. Nippon Rika Main Business and Markets Served
 Table 84. Nippon Rika Recent Developments/Updates
 Table 85. Chengyi Pharma Pharma Grade NAC (Acetylcysteine) Company Information
 Table 86. Chengyi Pharma Pharma Grade NAC (Acetylcysteine) Specification and Application
 Table 87. Chengyi Pharma Pharma Grade NAC (Acetylcysteine) Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 88. Chengyi Pharma Main Business and Markets Served
 Table 89. Chengyi Pharma Recent Developments/Updates
 Table 90. Wuhan Grand Hoyo Pharma Grade NAC (Acetylcysteine) Company Information
 Table 91. Wuhan Grand Hoyo Pharma Grade NAC (Acetylcysteine) Specification and Application
 Table 92. Wuhan Grand Hoyo Pharma Grade NAC (Acetylcysteine) Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 93. Wuhan Grand Hoyo Main Business and Markets Served
 Table 94. Wuhan Grand Hoyo Recent Developments/Updates
 Table 95. Manus Aktteva Biopharma Pharma Grade NAC (Acetylcysteine) Company Information
 Table 96. Manus Aktteva Biopharma Pharma Grade NAC (Acetylcysteine) Specification and Application
 Table 97. Manus Aktteva Biopharma Pharma Grade NAC (Acetylcysteine) Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 98. Manus Aktteva Biopharma Main Business and Markets Served
 Table 99. Manus Aktteva Biopharma Recent Developments/Updates
 Table 100. Shine Star Biological Pharma Grade NAC (Acetylcysteine) Company Information
 Table 101. Shine Star Biological Pharma Grade NAC (Acetylcysteine) Specification and Application
 Table 102. Shine Star Biological Pharma Grade NAC (Acetylcysteine) Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 103. Shine Star Biological Main Business and Markets Served
 Table 104. Shine Star Biological Recent Developments/Updates
 Table 105. Huachang Pharmaceutical Pharma Grade NAC (Acetylcysteine) Company Information
 Table 106. Huachang Pharmaceutical Pharma Grade NAC (Acetylcysteine) Specification and Application
 Table 107. Huachang Pharmaceutical Pharma Grade NAC (Acetylcysteine) Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 108. Huachang Pharmaceutical Main Business and Markets Served
 Table 109. Huachang Pharmaceutical Recent Developments/Updates
 Table 110. Xinhanling Biological Pharma Grade NAC (Acetylcysteine) Company Information
 Table 111. Xinhanling Biological Pharma Grade NAC (Acetylcysteine) Specification and Application
 Table 112. Xinhanling Biological Pharma Grade NAC (Acetylcysteine) Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 113. Xinhanling Biological Main Business and Markets Served
 Table 114. Xinhanling Biological Recent Developments/Updates
 Table 115. Shuguang Biological Pharma Grade NAC (Acetylcysteine) Company Information
 Table 116. Shuguang Biological Pharma Grade NAC (Acetylcysteine) Specification and Application
 Table 117. Shuguang Biological Pharma Grade NAC (Acetylcysteine) Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 118. Shuguang Biological Main Business and Markets Served
 Table 119. Shuguang Biological Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Pharma Grade NAC (Acetylcysteine) Distributors List
 Table 123. Pharma Grade NAC (Acetylcysteine) Customers List
 Table 124. Pharma Grade NAC (Acetylcysteine) Market Trends
 Table 125. Pharma Grade NAC (Acetylcysteine) Market Drivers
 Table 126. Pharma Grade NAC (Acetylcysteine) Market Challenges
 Table 127. Pharma Grade NAC (Acetylcysteine) Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pharma Grade NAC (Acetylcysteine)
 Figure 2. Global Pharma Grade NAC (Acetylcysteine) Market Value by Type, (US$ Million) & (2020-2031)
 Figure 3. Global Pharma Grade NAC (Acetylcysteine) Market Share by Type: 2024 VS 2031
 Figure 4. Injection Product Picture
 Figure 5. Granule for Oral Solution Product Picture
 Figure 6. Oral Inhalation Product Picture
 Figure 7. Effervescent Tablets Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Pharma Grade NAC (Acetylcysteine) Market Value by Application, (US$ Million) & (2020-2031)
 Figure 10. Global Pharma Grade NAC (Acetylcysteine) Market Share by Application: 2024 VS 2031
 Figure 11. Hospital
 Figure 12. Clinic
 Figure 13. Pharmacy
 Figure 14. Others
 Figure 15. Global Pharma Grade NAC (Acetylcysteine) Production Value (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Pharma Grade NAC (Acetylcysteine) Production Value (US$ Million) & (2020-2031)
 Figure 17. Global Pharma Grade NAC (Acetylcysteine) Production Capacity (Tons) & (2020-2031)
 Figure 18. Global Pharma Grade NAC (Acetylcysteine) Production (Tons) & (2020-2031)
 Figure 19. Global Pharma Grade NAC (Acetylcysteine) Average Price (US$/kg) & (2020-2031)
 Figure 20. Pharma Grade NAC (Acetylcysteine) Report Years Considered
 Figure 21. Pharma Grade NAC (Acetylcysteine) Production Share by Manufacturers in 2024
 Figure 22. Global Pharma Grade NAC (Acetylcysteine) Production Value Share by Manufacturers (2024)
 Figure 23. Pharma Grade NAC (Acetylcysteine) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. The Global 5 and 10 Largest Players: Market Share by Pharma Grade NAC (Acetylcysteine) Revenue in 2024
 Figure 25. Global Pharma Grade NAC (Acetylcysteine) Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 26. Global Pharma Grade NAC (Acetylcysteine) Production Value Market Share by Region: 2020 VS 2024 VS 2031
 Figure 27. Global Pharma Grade NAC (Acetylcysteine) Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 28. Global Pharma Grade NAC (Acetylcysteine) Production Market Share by Region: 2020 VS 2024 VS 2031
 Figure 29. North America Pharma Grade NAC (Acetylcysteine) Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 30. Europe Pharma Grade NAC (Acetylcysteine) Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 31. China Pharma Grade NAC (Acetylcysteine) Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 32. Japan Pharma Grade NAC (Acetylcysteine) Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 33. Global Pharma Grade NAC (Acetylcysteine) Consumption by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 34. Global Pharma Grade NAC (Acetylcysteine) Consumption Market Share by Region: 2020 VS 2024 VS 2031
 Figure 35. North America Pharma Grade NAC (Acetylcysteine) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 36. North America Pharma Grade NAC (Acetylcysteine) Consumption Market Share by Country (2020-2031)
 Figure 37. U.S. Pharma Grade NAC (Acetylcysteine) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 38. Canada Pharma Grade NAC (Acetylcysteine) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 39. Europe Pharma Grade NAC (Acetylcysteine) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 40. Europe Pharma Grade NAC (Acetylcysteine) Consumption Market Share by Country (2020-2031)
 Figure 41. Germany Pharma Grade NAC (Acetylcysteine) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 42. France Pharma Grade NAC (Acetylcysteine) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 43. U.K. Pharma Grade NAC (Acetylcysteine) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 44. Italy Pharma Grade NAC (Acetylcysteine) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 45. Russia Pharma Grade NAC (Acetylcysteine) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 46. Asia Pacific Pharma Grade NAC (Acetylcysteine) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 47. Asia Pacific Pharma Grade NAC (Acetylcysteine) Consumption Market Share by Region (2020-2031)
 Figure 48. China Pharma Grade NAC (Acetylcysteine) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 49. Japan Pharma Grade NAC (Acetylcysteine) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 50. South Korea Pharma Grade NAC (Acetylcysteine) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 51. China Taiwan Pharma Grade NAC (Acetylcysteine) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 52. Southeast Asia Pharma Grade NAC (Acetylcysteine) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 53. India Pharma Grade NAC (Acetylcysteine) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 54. Latin America, Middle East & Africa Pharma Grade NAC (Acetylcysteine) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 55. Latin America, Middle East & Africa Pharma Grade NAC (Acetylcysteine) Consumption Market Share by Country (2020-2031)
 Figure 56. Mexico Pharma Grade NAC (Acetylcysteine) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 57. Brazil Pharma Grade NAC (Acetylcysteine) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 58. Turkey Pharma Grade NAC (Acetylcysteine) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 59. GCC Countries Pharma Grade NAC (Acetylcysteine) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 60. Global Production Market Share of Pharma Grade NAC (Acetylcysteine) by Type (2020-2031)
 Figure 61. Global Production Value Market Share of Pharma Grade NAC (Acetylcysteine) by Type (2020-2031)
 Figure 62. Global Pharma Grade NAC (Acetylcysteine) Price (US$/kg) by Type (2020-2031)
 Figure 63. Global Production Market Share of Pharma Grade NAC (Acetylcysteine) by Application (2020-2031)
 Figure 64. Global Production Value Market Share of Pharma Grade NAC (Acetylcysteine) by Application (2020-2031)
 Figure 65. Global Pharma Grade NAC (Acetylcysteine) Price (US$/kg) by Application (2020-2031)
 Figure 66. Pharma Grade NAC (Acetylcysteine) Value Chain
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India